3 beaten-down ASX 200 stocks tipped to rocket over 100% higher 

Find out what the experts expect from these shares in 2026.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) reached a new all-time high on Wednesday. And while many big achievers helped drive the index to new highs, some beaten-down shares have moved in the opposite direction.

But not all of them will continue spiralling.

Here are three ASX 200 stocks that are expected to stage a turnaround this year. And some could climb as high as 100%, or even more.

Three businesspeople leap high with the CBD in the background.

Image source: Getty Images

Xero Ltd (ASX: XRO)

Xero shares were in the green on Wednesday afternoon, but the stock is still down nearly 60% over the past 12 months. 

The cloud-based accounting software company was caught up in the sector-wide tech sell-off and AI-related nervousness late last year (and into early 2026). This, combined with investor worry about the company's Melio acquisition, and potentially overvalued share price, saw many sell up. 

But Xero's business model, which is often referred to as "sticky",  has recurring revenue, global exposure, and profitability. It's actively expanding its presence and its product suite, too. 

I think there's a chance that the ASX 200 stock could double in value in 2026. Some analysts think it could storm even higher. Data shows the majority (12 out of 13) have a buy or strong buy rating on the stock with a maximum target price of $229.89 a piece. That implies a huge potential 204.98% upside at the time of writing.

Pro Medicus Ltd (ASX: PME)

Pro Medicus shares enjoyed a reprieve on Wednesday and closed in the green for the day. It comes off the back of a long string of declines due to similar sector-wide headwinds, which affected Xero stock.

Three of the company's directors have increased their existing stake by purchasing additional Pro Medicus shares, which raises a green flag for other investors. 

Out of 14 analysts, nine have a buy or strong buy rating on the stock. The average target price is $220.75, which implies a 91.57% upside at the time of writing. However, some think it could soar even higher to $300 a piece. That represents a potential 160.35% upside for Pro Medicus shares.

WiseTech Global Ltd (ASX: WTC)

WiseTech shares jumped over 10% after the company posted its half-year results on Wednesday morning. From an AFP and ASIC raise to a boardroom fallout, the logistics software company has sent WiseTech shares crashing over the past 8 months.

But investors are happy with the latest results announcement, suggesting that investor sentiment could finally be turning a corner for the beaten-down ASX 200 stock.

Most analysts already had a strong buy rating on the tech stock, with a maximum target price of $167.64 over the next 12 months. Even after Wednesday's rally, that implies a huge 253.23% upside for investors at the time of writing.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A group of people in suits watch as a man puts his hand up to take the opportunity.
Growth Shares

A rare buying opportunity to buy 1 of Australia's top shares?

This stock has a lot to offer for investors wanting to beat the market…

Read more »

Red buy button on an Apple keyboard with a finger on it.
Growth Shares

2 little-known ASX shares that could make big returns

Experts are bullish about the potential of these stocks.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Growth Shares

2 high-quality ASX stocks to buy and hold long term

Brokers see the dip as a compelling long-term buy with 33% to 44% upside.

Read more »

a man wearing casual clothes fans a selection of Australian banknotes over his chin with an excited, widemouthed expression on his face.
Growth Shares

3 fantastic ASX shares that could help build long-term wealth

Analysts think these shares are in the buy zone right now.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Growth Shares

2 ASX 200 shares I rate as top buys for growth

These sizeable businesses could scale significantly from here…

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

Where to invest $7,000 in ASX shares during April

I’m optimistic that these ASX shares could beat the stock market.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Growth Shares

3 ASX 200 shares that could quietly compound for years

Let's see what sets these shares apart from the crowd.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Growth Shares

3 ASX shares tipped to grow 100% or more in the next 12 months

Here’s how much these exciting stocks could rise in the year ahead.

Read more »